Objective: To evaluate the expectations, experiences, and satisfaction with the Iowa Priority Prescription Savings (IPPS) program.

Design: Longitudinal descriptive study.

Setting: Iowa.

Participants: Randomly selected Iowa Medicare beneficiaries who self-enrolled in the IPPS prescription discount card program.

Interventions: Three self-administered surveys mailed in November 2002, June 2003, and September 2004, during the first, second, and third years of IPPS operation.

Main Outcome Measures: Expectations of drug discounts, amount of discounts received, awareness of the IPPS preferred drug list (PDL), and satisfaction with the program.

Results: Usable response rates for the three surveys were 43.5%, 31.0%, and 38.4%. About one fourth of members initially expected discounts of more than 20% on their prescription medications. After IPPS was implemented, many members were unaware of the discounts they were receiving, but the percentage of members reporting discounts of more than $20 per month increased from 7.4% in year 1 to 16.4% in year 3. More than one half of the members were unaware of which drugs were on the PDL in years 1 and 2, but this improved to 21% unawareness in year 3. Satisfaction with the program was low but improved over time. Members who received discounts, did not expect large discounts, or received a medication review were more satisfied with the program.

Conclusion: Some IPPS members had unrealistic expectations about the amount of discounts they would receive, and expectations of large discounts decreased satisfaction. Satisfaction and amount of discounts improved over time, and beneficiaries whose medications were reviewed, usually by a pharmacist, were more satisfied with the program. PDL awareness was a problem despite substantial educational efforts by IPPS, a finding that has implications for the recently implemented Medicare Part D drug benefit.

Download full-text PDF

Source
http://dx.doi.org/10.1331/1544-3191.46.6.715.ganther-urmieDOI Listing

Publication Analysis

Top Keywords

amount discounts
12
discounts
10
iowa medicare
8
discount card
8
preferred drug
8
drug list
8
discounts received
8
members unaware
8
improved time
8
large discounts
8

Similar Publications

A wearable alcohol biosensor: Exploring the accuracy of transdermal drinking detection.

Drug Alcohol Depend

November 2024

School of Information Sciences, University of Illinois Urbana-Champaign, Champaign, IL 61820, USA; Department of Educational Psychology, University of Illinois Urbana-Champaign, Champaign, IL 61820, USA.

Background: Trace amounts of consumed alcohol are detectable within sweat and insensible perspiration. However, the relationship between ingested and transdermally emitted alcohol is complex, varying across environmental conditions and involving a degree of lag. As such, the feasibility of real-time drinking detection across diverse environments has been unclear.

View Article and Find Full Text PDF

Study Question: What is the governmental fiscal impact of a new assisted reproduction subsidy scheme based on projected lifetime net taxes attributed to resulting live births in Taiwan?

Summary Answer: We estimate that the new fertility reimbursement scheme has generated favorable lifetime fiscal gains for the Taiwanese government, resulting in a return on investment (ROI) of NT$5.6 for every NT$1.0 spent based on those families receiving public subsidies for fertility care under the new scheme.

View Article and Find Full Text PDF

Borrowing using historical-bias power prior with empirical Bayes.

J Biopharm Stat

December 2024

Department of Statistics, Florida State University, Tallahassee, USA.

Adaptively incorporating historical information into analyses of current data can improve the precision of inference without requiring additional new observation. Unfortunately, not all borrowing methods are suitable when limited historical studies are available. When a single historical study is available, the power priors control the amount of information to borrow via specification of a weight parameter that discounts the contribution of the historical data in a likelihood combined with current data.

View Article and Find Full Text PDF

Disinformation on dietary supplements by German influencers on Instagram.

Naunyn Schmiedebergs Arch Pharmacol

November 2024

Institute of Pharmacology, Hannover Medical School, Carl-Neuberg-Str. 1, D-30655, Hanover, Germany.

A significant proportion of the German population regularly consumes dietary supplements (NEM), and the market for these products is growing steadily. Dietary supplements are subject to food law and not pharmaceutical law. There are no official limits for the dosages of vitamins and minerals in Germany-only recommendations from institutions such as the Bundesinstitut für Risikobewertung (BfR) or the European Food Safety Authority (EFSA).

View Article and Find Full Text PDF

Comparison of Borrowing Methods for Incorporating Historical Data in Single-Arm Phase II Clinical Trials.

Ther Innov Regul Sci

November 2024

Centre for Biostatistics, Epidemiology and Public Health, Department of Clinical and Biological Sciences, University of Turin, Regione Gonzole 10, Orbassano, 10043, Italy.

Background: Over the last few years, many efforts have been made to leverage historical information in clinical trials. Incorporating historical data into current trials allows for a more efficient design, smaller studies, or shorter duration and may potentially increase the relative amount of information on efficacy and safety. Despite these advantages, it is crucial to select external data sources appropriately to avoid introducing potential bias into the new study.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!